PubMed ID:
24311704
Public Release Type:
Journal
Publication Year: 2014
Affiliation: Department of Pediatrics, University of California, San Francisco, California;, †Department of Medicine and, §Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida;, ‡Department of Pediatrics, Harvard Medical School, Boston, Massachusetts;, ‖Department of Pediatrics, Weill Cornell Medical College, New York, New York;, ¶Department of Pediatrics, University of California, Los Angeles, California;, *Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York;, ††Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, ‡‡Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
DOI:
https://doi.org/10.2215/CJN.05840513
Authors:
Jüppner H,
Portale AA,
Salusky IB,
Warady BA,
Furth SL,
Schwartz GJ,
Wesseling-Perry K,
Kumar J,
Messinger S,
Wolf M
Studies:
The Chronic Kidney Disease in Children Cohort Study
In children with CKD, information is limited regarding the prevalence and determinants of fibroblast growth factor 23 excess and 1,25-dihyroxyvitamin D deficiency across the spectrum of predialysis CKD. This study characterized circulating concentrations of fibroblast growth factor 23 and 1,25-dihyroxyvitamin D, and investigated their interrelationships and associations with GFR and secondary hyperparathyroidism in children with CKD who were enrolled in the Chronic Kidney Disease in Children observational cohort study.